Soru

Zorluk: ZorPreoperative and Postoperative Care

A 24-year-old male with no significant past medical history is undergoing an elective open reduction and internal fixation of a right clavicle fracture. Induction of general anesthesia is achieved with propofol and succinylcholine, and anesthesia is maintained with sevoflurane. Thirty minutes into the procedure, the anesthesiologist notes a sudden and abrupt rise in the end-tidal carbon dioxide (ETCO2ETCO_2) to 78 mmHg78\text{ mmHg}. The patient develops generalized muscle rigidity, most notably in the masseter muscles. His core body temperature begins to rise rapidly and is currently 39.5∘C39.5^\circ\text{C} (103.1∘F103.1^\circ\text{F}). His heart rate is 152/min152\text{/min}, and blood pressure is 155/95 mmHg155/95\text{ mmHg}.

Arrange the following management steps in the most appropriate chronological priority order for this patient's acute perioperative complication.

  1. 1Discontinue the administration of sevoflurane and succinylcholine.
  2. 2Hyperventilate the patient with 100% oxygen using high fresh gas flow rates.
  3. 3Administer intravenous dantrolene.
  4. 4Administer intravenous calcium chloride, regular insulin, and dextrose.

Cevap

The correct sequence is to first discontinue the triggering agents, followed by hyperventilation with 100% oxygen, then administration of intravenous dantrolene, and finally the management of severe metabolic derangements such as hyperkalemia.
Malignant hyperthermia is a life-threatening perioperative emergency requiring a highly specific algorithmic approach. The absolute first step is source control: discontinuing the offending agents (volatile anesthetics and depolarizing neuromuscular blockers). Immediately following this, the clinician must hyperventilate the patient with 100% oxygen using high fresh gas flows to clear residual anesthetic vapor from the machine and circuit, while simultaneously treating the profound hypercarbia and hypoxia. Once these immediate life-support steps are initiated, the definitive antidote, intravenous dantrolene, must be administered to block the ryanodine receptor and halt calcium release. Finally, the downstream consequences of the massive hypermetabolic state and rhabdomyolysis, such as severe hyperkalemia and metabolic acidosis, are treated with appropriate adjuncts like calcium chloride, insulin, and dextrose.

Adım Adım Çözüm

1
Identify the clinical syndrome.
The patient is experiencing malignant hyperthermia, characterized by hypercarbia, rigidity, and hyperthermia after exposure to sevoflurane and succinylcholine.
Accurate recognition of this hypermetabolic crisis dictates immediate, highly specific algorithmic management.
2
Prioritize immediate source control.
Discontinue sevoflurane and succinylcholine.
Continuing the triggering agents will perpetuate the uncontrolled intracellular calcium release, rendering all other interventions futile.
3
Ensure adequate gas exchange and clearance of residual anesthetics.
Hyperventilate with 100% oxygen at maximum fresh gas flow rates.
This flushes the remaining volatile anesthetic from the anesthesia machine and patient's lungs while treating the severe respiratory acidosis.
4
Administer the definitive antidote.
Give intravenous dantrolene.
Dantrolene binds to the ryanodine receptor (RYR1), blocking the release of calcium from the sarcoplasmic reticulum and halting the hypermetabolic process.
5
Treat secondary life-threatening complications.
Administer calcium chloride, insulin, and dextrose to treat hyperkalemia.
Muscle breakdown releases massive amounts of potassium, which can rapidly cause fatal cardiac arrhythmias if not shifted intracellularly and stabilized.

Anahtar Kavram

The management of malignant hyperthermia requires a strict chronological sequence: immediately stopping the triggering agents, hyperventilating with 100% oxygen, administering dantrolene, and subsequently treating metabolic derangements and hyperthermia.
Tahmini Süre:1m 30s
Bu soruyu puanla